Abstract:Aim: To construct the bicistronic eukaryotic expression plasmid containing human bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor 165 (VEGF-165)genes. Methods: This experiment was conducted at the Common Experimental Flatform of Tongji Medical College, Huazhong University of Science and Technology from March 2005 to October 2005. 1 Through polymerase chain reaction, target gene segment of pcDNA3.1-BMP2 and pUC-CAGGS-VEGF165 were subcloned and new estriction enzyme cutting sites were inducted, then were directionally connected to eukaryotic expression vector pIRES, bicistronic mRNA of two target gene was expressed when constructing. Recombinant plasmid was identified through polymerase chain reaction, enzyme analysis and DNA sequencing. 2 Recombinant plasmid transfected in vitro mouse bone marrow stroma cell induced by liposome. The expression of BMP-2 and VEGF-165 genes was detected through reverse transcriptase-polymerase chain reaction. Results: 1 Construction and id entification of bicistronic eukaryotic expression plasmid pIRES-BMP2-VEGF165: Recombinant plasmid pIRES-BM P2-VEGF165 was treated with Xho I/Mlu I and Xba I /Not I. Electropherosis of 1% agarose showed that there were 1.2 kbp human BMP-2 band and 592 bp vascular endothelial growth factor 165 band enzyme band and the electropherosis band of polymerase chain reaction were placed in the same position. Polymerase chain reaction, enzyme analysis and DNA sequencing proved that the inserting segment direction of target gene was right and no mutation appeared in DNA sequencing. 2 Expression of BMP-2 and VEGF-165 mRNA: transfected pIRES empty plasmid was as negative control, RNA of transfected cells was extracted 48 hours later, then were performed reverse transcriptase-polymerase chain reaction with P1, P2, P3, and P4 as primer. Results demonstrated that mouse bone marrow stroma cell with transfected pIRES-HMP2-VEGF165 amplified 1.2 kbp and 592 bp two bands, which proved that this recombinant plasmid could co-express in vitro bicistronic eukaryotic expression plasmid containing BMP-2 and VEGF-165 mRNA. Conclusion: Bicistronic eukaryotic expression plasmids containing BMP-2 and VEGF-165 mRNA are constructed successfully, which provide the foundation for combination gene therapy in bone defect.

Construction and Application of an Eukaryotic System for Biotinylat-ed Protein

Constructing Prokaryotic Vector of BC047440 Gene Expression and Purification of Its Recombinant Protein

A one‐process production of completely biotinylated proteins in a T7 expression system

[Prokaryotic Expression of BirA Enzyme and Identification of the Bioactivity of Expressed Product].

Construction and Expression of Recombinant Acetylcholine Receptor Α Subunit -Bira Recognition Polypeptide Sequence Gene

Engineering a heterologous synthetic pathway in Escherichia coli for efficient production of biotin

Construction,expression and Characterization of Recombinant Fusion Protein HSA-PTH(1-34) in Pichia Pastoris

[Expression of (His)(6)-Eif3s4 Fusion Protein in Human Breast Cancer Cell Bcap37].

Genetically Encoded Biotin Analogues: Incorporation and Application in Bacterial and Mammalian Cells

Rapid Fabrication of Protein Microarrays via Autogeneration and on-Chip Purification of Biotinylated Probes

Construction and Application of Prokaryotic Expression Plasmid Containing GST and His Tags

Construction of Apoptin Fusion Gene Prokaryotic Expression Vector and Its Soluble Expression

Construction of a prokaryotic expression vector for Apoptin and expression in E.coli

Supplementary Methods Site-Specific Labeling of Cell Surface Proteins with Biophysical Probes using Biotin Ligase

Construction of a prokaryotie expression vector for apoptin and preparation of polyelonal antibody of apoptin

BirA*-protein A fusion protein based BioEnhancer amplifies western blot immunosignal

Construction and Expression of the Prokaryotic Expression Vector for High Frequency Allele HLA-A* 1101 Heavy-Chain Ectodomain Fused with BSP

[Construction of a Prokaryotic Expression Vector for Apoptin and Preparation of Polyclonal Antibody of Apoptin].

Construction and in vitro expression of bicistronic eukaryotic expression plasmid containing human bone morphogenetic protein-2 and vascular endothelial growth factor 165 genes

Detection of Recombinant Proteins SOX2 and OCT4 Interacting in HEK293T Cells Using Real-Time Quantitative PCR

AviTrap: A novel solution to achieve complete biotinylation